Friday 6 November 2026 Export MIRM’s income statement to Excel — free account

Mirum Pharmaceuticals, Inc.

Mirum Pharmaceuticals, Inc.’s revenue for fiscal 2025 (year ended December 2025) was $521.3 million, up 54.7% from fiscal 2024.

Revenue: +39.6%
EPS: −1,136.8%
Free cash flow: −114.2%
Total debt: +136.4%

Quarter to September 2026, against a year earlier

93.82 0.28 +0.30%

Follow MIRM

Alert me

Market cap: $6.1B
P/E: 0.0×
Fwd P/E: −5.6×
Dividend yield: —
F-score: 6/9
Altman Z: 4.42
Beneish M: −2.46
Dividend safety: n/a

Overview

Mirum Pharmaceuticals, Inc. (MIRM) Current ratio

Alert me on Current ratio

Mirum Pharmaceuticals, Inc.'s current ratio at the end of the quarter to 30 September 2026 was 2.1×, down 0.6× from fiscal 2025 (2.7×). Over the past ten years it has ranged from 2.7× (fiscal 2025) to 21.2× (fiscal 2018) — the current reading is the lowest in ten years. That is below the Biotechnology industry median of 4.9× and below the Healthcare sector median of 3.1×.

Embed this chart

Code for your page

<iframe src="https://stockrow.com/embed/MIRM/current-ratio" width="100%" height="360" style="border:0" loading="lazy" title="Mirum Pharmaceuticals, Inc. current ratio, 10 years"></iframe>
<p style="font-size:12px">Source: <a href="https://stockrow.com/MIRM/metrics/current-ratio">Mirum Pharmaceuticals, Inc. (MIRM) current ratio — stockrow.com</a></p>

Period	Current ratio	Change
FY2025	2.7×	(13.94%)
FY2024	3.1×	(30.27%)
FY2023	4.5×	51.46%
FY2022	2.9×	(24.86%)
FY2021	3.9×	(69.45%)
FY2020	12.8×	40.24%
FY2019	9.1×	(56.99%)
FY2018	21.2×	—

Period	Current ratio	Change
Sep 2026	2.1×	(27.44%)
Jun 2026	2.9×	36.84%
Mar 2026	2.1×	(21.86%)
Dec 2025	2.7×	(19.27%)
27 more quarters	Free account

Against its own ten years

Low 2.7× High 21.2×

Ten-year median 4.2×

Current reading's percentile 13

Company	Current ratio
ORKA Oruka Therapeutics, Inc. compare	38.5×
BLTE Belite Bio, Inc. Sponsored ADR compare	33.6×
CGON CG Oncology, Inc. compare	22.2×
IONS Ionis Pharmaceuticals, Inc. compare	7.9×
IMVT Immunovant, Inc. compare	7.3×
PTCT PTC Therapeutics, Inc. compare	3.3×
KOD Kodiak Sciences Inc. compare	2.5×
MIRM Mirum Pharmaceuticals, Inc.	2.1×
LGND Ligand Pharmaceuticals Incorporated compare	1.2×
Biotechnology industry median	4.9×
Healthcare sector median	3.1×
Market median	1.6×

What Current ratio is

Current Ratio shows whether a company’s short-term assets are enough to cover the bills and debts it must pay within the next year.

Current Assets (Total) ÷ Current Liabilities (Total)

The full definition of Current ratio →

Mirum Pharmaceuticals, Inc. (MIRM) Current ratio

Current ratio, annual

Annual newest first

Quarterly newest first

Against its own ten years

Current ratio against peers

What Current ratio is

More on MIRM

Current ratio, annual

Annual newest first

Quarterly newest first

Against its own ten years

Current ratio against peers

What Current ratio is

More on MIRM

Stockrow Weekly